Inspire Medical Systems, Inc. revised revenue guidance for the full year 2023. For the year, the company expects revenue guidance to between $608 million to $612 million, which represents growth of 49% to 50% over full year 2022 revenue of $407.9 million. This compares to the prior revenue guidance of $600 million to $610 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
157.6 USD | -0.61% | -3.87% | -22.78% |
08/05 | Top Premarket Decliners | MT |
07/05 | Transcript : Inspire Medical Systems, Inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.78% | 471.19Cr | |
+10.26% | 12TCr | |
-5.29% | 1.12TCr | |
+4.17% | 916.62Cr | |
+8.74% | 344.12Cr | |
-5.09% | 287.97Cr | |
-12.05% | 211.11Cr | |
-7.83% | 209.29Cr | |
-22.84% | 179.8Cr | |
-8.81% | 116.7Cr |
- Stock Market
- Equities
- INSP Stock
- News Inspire Medical Systems, Inc.
- Inspire Medical Systems, Inc. Revises Revenue Guidance for the Full Year 2023